Tradestie Institutional Equity Comparison Engine
SZK vs RXD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RXD Overall Edge
RXD Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares UltraShort Health Care (RXD) driven by superior Options & Structure while SZK counters with relative strength in Momentum & Technical. Fundamentally, SZK trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus RXD at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, SZK sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against RXD sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SZK N/M vs RXD N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
SZK
1Y +29.0% vs +26.9% ยท 52W Pos 55% vs 29%
Options & Structure Winner
RXD
UNCLASSIFIED (2nd %ile IV) vs UNCLASSIFIED (<1st %ile IV)
SZK
NYSE Arca
ProShares UltraShort Consumer Staples
Institutional Equity
$16.91
-0.59% 1D
Market Cap
N/A
1M Return
-10.81%
1Y Return
+29.0%
Forward P/E
N/M
Unified AI Score
40.7 / 100
SELL
Tech 24.0
Fund 47.0
Flow 50.0
Mom 60.0
RXD
NYSE Arca
ProShares UltraShort Health Care
Institutional Equity
$11.95
+1.01% 1D
Market Cap
N/A
1M Return
-11.84%
1Y Return
+26.9%
Forward P/E
N/M
Unified AI Score
58.1 / 100
HOLD
Tech 80.0
Fund 66.0
Flow 50.0
Mom 68.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SZK +29.0%
RXD +26.9%
Spread: +2.1 pp (SZK Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SZK TTM Op. Margin: N/A
RXD TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SZK vs RXD. Trailing 12-month operating profitability (SZK N/A vs RXD N/A) and valuation multiples (SZK N/M vs RXD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SZK | RXD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 55% ($9โ$23) | 29% ($8โ$21) | Stronger Trend | SZK |
| Beta / 30D Volatility Risk Regime | 0.44ฮฒ ยท 46% Vol | -0.21ฮฒ ยท 40% Vol | Lower Realized Risk | RXD |
| Unified Institutional Score Composite Signal | 40.7 / 100 (SELL) | 58.1 / 100 (HOLD) | Higher Composite | RXD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SZK vs RXD Buy Guide
SZK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
RXD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SZK nor RXD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.